UCB Japan Co. Ltd.
π―π΅Japan
- Country
- π―π΅Japan
- Ownership
- Subsidiary
- Established
- 1988-04-28
- Employees
- 501
- Market Cap
- -
- Website
- http://www.ucbjapan.com
Clinical Trials
14
Active:0
Completed:14
Trial Phases
3 Phases
Phase 1:1
Phase 2:3
Phase 3:10
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (14 trials with phase data)β’ Click on a phase to view related trials
Phase 3
10 (71.4%)Phase 2
3 (21.4%)Phase 1
1 (7.1%)A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age
- First Posted Date
- 2017-11-13
- Last Posted Date
- 2024-07-23
- Lead Sponsor
- UCB Japan Co. Ltd.
- Target Recruit Count
- 38
- Registration Number
- NCT03340064
- Locations
- π―π΅
Ep0100 15, Fukuoka, Japan
π―π΅EP0100 3, Hamamatsu, Japan
π―π΅EP0100 6, Izumi, Japan
Open-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onset Seizures
Phase 3
Completed
- Conditions
- Partial-onset SeizuresEpilepsy
- Interventions
- First Posted Date
- 2014-07-17
- Last Posted Date
- 2017-08-25
- Lead Sponsor
- UCB Japan Co. Ltd.
- Target Recruit Count
- 9
- Registration Number
- NCT02192814
- Locations
- π―π΅
81027, Hamamatsu, Japan
π―π΅81024, Kodaira, Japan
π―π΅81025, Sapporo, Japan
A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures
- First Posted Date
- 2014-04-28
- Last Posted Date
- 2019-10-28
- Lead Sponsor
- UCB Japan Co. Ltd.
- Target Recruit Count
- 19
- Registration Number
- NCT02124564
- Locations
- π―π΅
5, Asaka, Japan
π―π΅1, Hamamatsu, Japan
π―π΅11, Itami, Japan
Multiple-dose Study of Levetiracetam Injection in Japanese and Caucasian Healthy Males
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2012-11-12
- Last Posted Date
- 2013-03-29
- Lead Sponsor
- UCB Japan Co. Ltd.
- Target Recruit Count
- 32
- Registration Number
- NCT01725009
- Locations
- π―π΅
01, Tokyo, Japan
An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy
- First Posted Date
- 2012-01-10
- Last Posted Date
- 2015-12-31
- Lead Sponsor
- UCB Japan Co. Ltd.
- Target Recruit Count
- 71
- Registration Number
- NCT01506882
- Locations
- π―π΅
19, Aomori, Japan
π―π΅33, Asaka, Japan
π―π΅21, Daito, Japan
- Prev
- 1
- 2
- 3
- Next
News
No news found